| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.91B | +18.2% |
| Cost of Revenue | $1.81B | +19.2% |
| Gross Profit | $1.10B | +16.4% |
| R&D Expense | $60.4M | +24.3% |
| SG&A Expense | $595.9M | +10.8% |
| Operating Income | $440.4M | +23.9% |
| Interest Expense | $31.2M | -3.4% |
| Pre-tax Income | $472.6M | +47.4% |
| Income Tax | $72.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $297.5M | +501.0% |
| Inventory | $346.7M | +7.7% |
| Current Assets | $1.23B | +34.9% |
| Total Assets | $4.90B | +4.9% |
| Current Liabilities | $649.5M | +2.1% |
| Long-term Debt | $1.08B | +8.4% |
| Total Liabilities | $2.17B | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $394.6M | +5.7% |
| Capital Expenditures | $45.9M | +16.2% |
| Investing Cash Flow | -$52.5M | +80.8% |
| Financing Cash Flow | -$82.1M | +50.8% |
| Free Cash Flow | $348.7M | +4.5% |
| +52.3% |
| Net Income | $399.8M | +46.5% |
| EPS (Basic) | $2.40 | +47.2% |
| EPS (Diluted) | $2.38 | +47.8% |
| Stockholders' Equity |
| $2.73B |
| +9.4% |